documents: FDA-2013-N-1524-0298
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | agency_id | docket_id | title | document_type | subtype | posted_date | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2013-N-1524-0298 | FDA | FDA-2013-N-1524 | Bulk Drug Substances That May Be Used To Compound Drug Products in Accordance With Section 503B of the Federal Food, Drug, and Cosmetic Act, Concerning Outsourcing Facilities; Revised Request for Nominations | Notice | Request for Nominations | 2014-07-02T04:00:00Z | 2014 | 7 | 2014-07-02T04:00:00Z | 2014-10-01T03:59:59Z | 2015-07-23T01:30:24Z | 2014-15373 | 0 | 0 | 090000648178723a |
Links from other tables
- 1 row from regs_document_id in fr_regs_crossref